# VHsquared

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/vhsquared

- Industry: Biotechnology
- Headquarters: Cambridge, UK
- Website: www.vhsquared.com
- Total disclosed funding: $19M
- Latest round: Series A (Apr 14, 2016)
- Investors on record: 5

## About

VHsquared Ltd. specializes in providing innovative technology solutions aimed at enhancing operational efficiencies for business clients across diverse sectors, facilitating data-driven decision-making through advanced software applications.Founded in 2010, VHsquared Ltd. is based in Cambridge, UK, and focuses on delivering software solutions for data management and analytics. The company has raised a total of GBP 10.97 million in Series A funding from SV Health Investors. The latest funding round was completed on April 14, 2016, valuing the company at GBP 20.10 million post-money. The CEO, Rod Richards, leads the company in its mission to improve client efficiencies through technology solutions.VHsquared Ltd. specializes in innovative technology solutions that enhance operational efficiencies for business clients. The company’s core offerings encompass a suite of software applications for data management and analytics, designed to streamline processes and support data-driven decisions. These applications focus on user experience and scalability, tailored for use cases like resource allocation, customer relationship management, and performance tracking. VHsquared predominantly serves a diverse clientele, including small to medium enterprises, large corporations, and government agencies across technology, healthcare, and education sectors. Its products are marketed globally, reaching clients in North America, Europe, and selected markets in Asia.VHsquared Ltd. operates on a subscription-based revenue model, allowing clients to access its software solutions through tiered pricing plans. Customers pay monthly or annual fees based on their chosen package, which matches their needs and scale. The company's flagship analytics platform features varying price points, influenced by the included capabilities, ranging from basic data reporting to advanced predictive analytics. Transactions are primarily direct-to-consumer, enabling clients to engage directly with VHsquared through its website or sales representatives to customize their subscription plans. This model fosters recurring revenue and strengthens long-term client relationships by providing ongoing access to product updates and support services.VHsquared Ltd. plans to leverage its recent funding of GBP 10.97 million from the Series A round to support the development of new product offerings and expand into new markets. Specific upcoming products include enhancements to its analytics platform, with a focus on user feedback to improve functionality. The company aims to target expansion into additional regions in Asia by 2024, seeking to penetrate markets where demand for data solutions is increasing. The funds raised will be utilized to bolster product development and sales efforts, ensuring successful entry into these new markets.

## Funding rounds

- Series A, Apr 14, 2016, $16M — SV Health Investors
- Series A, Dec 31, 2013 — SR One, Lundbeckfond Ventures
- Seed, Dec 22, 2010, $3.4M — Wellcome Trust, Unilever Ventures

## Investors

- Wellcome Trust — Seed
- Unilever Ventures (https://capitalatlas.ai/funds/unilever-ventures) — Seed
- SR One (https://capitalatlas.ai/funds/sr-one) — Series A
- Lundbeckfond Ventures (https://capitalatlas.ai/funds/lundbeckfond-ventures) — Series A
- SV Health Investors (https://capitalatlas.ai/funds/sv-health-investors) — Series A